Key facts
- It has raised $3.0M; the latest was Seed Round ($3.0M) in Oct 2025.
- Notable investors include MedTech Innovator, University of California, UpHonest Capital, MassRobotics, Berkeley — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for ATDev
- ·The full record, as it builds
Funding rounds
No funding rounds for ATDev are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ATDev
Developer of mobility devices designed to launch scalable physical therapy to patients across the US and globally. The company's devices reimagine physical therapy through robotics to transform access to care and tracking of patient outcomes through telehealth services, enabling doctors to reduce barriers to physical therapy and improve the quality of care for individuals who have undergone knee surgery.
- Sector
- Healthcare
- HQ
- Orange, CA, United States
- Founded
- 2020
- Employees
- 10
- Website
- assistivetech.dev/
- Ownership
- Privately Held (backing)
ATDev doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ATDev shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ATDev in its N-PORT filings yet. We sweep new filings monthly.